Skip to main content
. 2017 Aug 3;16:311. doi: 10.1186/s12936-017-1963-0

Table 5.

Results for AQSP and the WHO-recommended ACT medicines

Rank probabilities
Treatments Odds ratios 95% CrI Rank 1 Rank 2 Rank 3
AL 0 10−5 10−4
AQSP 0.87 0.50–1.51 0.0004 10−4 0.005
ASAQ 1.12 0.82–1.54 0.00 10−4 0.007
ASMQ 1.20 0.52–2.80 0.0016 0.05 0.08
ASSP 1.35 0.71–2.58 0.01 0.05 0.10
DHAP 1.92 1.29–2.83 0.04 0.20 0.30

A total of 76 studies were analysed using the random effect model 2 under the hypothesis of consistency. Treatments were numbered as the first six combinations. Posterior distributions of odds ratio and 95% credible intervals (CrI) were extracted. AL was the comparator. Posterior rank probabilities are given for ranks 1, 2 and 3. In this model, DHAP was shown to be the most efficacious among the combination therapies